Dr. Mack C. Mitchell Joins HepaTx Clinical Advisory Board
| FEATURE | Jul 10, 2023

HepaTx Welcomes Transplant Hepatologist Julio Gutierrez, MD to the Clinical Advisory Board
| FEATURE | May 18, 2023

Professor Mark Thursz Joins the Hepatx Scientific Advisory Board to Advance Liver Disease Treatment
| FEATURE | Apr 13, 2023

Mazen Noureddin, MD, MHSc joins HepaTx's Scientific Advisory Board
| FEATURE | Mar 7, 2023

HepaTx Awarded 2022 Impact Company of The Year Award by DotCom Magazine
| FEATURE | Feb 15, 2022

HepaTx appoints Salah Kivlighn, PhD as new CEO
| FEATURE | Apr 15, 2021

‘HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases’
| FEATURE | Mar 12, 2021

‘Here are the 63 Startups that Launched at Y Combinator’s Demo Day S18’
| FEATURE | Aug 20, 2018

Deep Tech Show | Regenerative Liver Technologies + Dr.Eric Schuur
| LISTEN | Feb 14, 2023

Builders of Biotech | Episode 2: Eric Schuur, CEO of HepaTx
| LISTEN | Jan 22, 2023

‘The Cover Stories: A DotCom Magazine Interview with Salah Kivlighn, Ph.D. , CEO’
| INTERVIEW | Feb 2022

Cell Therapy Reimagined and Our Technology - Clip from DotCom Magazine Interview with Salah Kivlighn

‘Grow Your Own New Organs with Eric Schuur’ | Ep. 17
| PODCAST | Dec 18, 2020

‘Stem Cell Therapy Solutions for Liver Disease’
| VIDEO | Dec 5, 2018

‘Beneath the surface of the pandemic: Persons with alcohol-associated liver disease need our attention’
| LETTER TO EDITOR | Feb 24, 2022

‘The Pitch: HepaTx Offers a New Life for Failing Livers’
| ARTICLE | Nov 3, 2016